{"id":"de-escalation-strategy","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"De-escalation is a therapeutic strategy rather than a specific drug, involving stepwise reduction of antimicrobial agents, chemotherapy, or other medications after initial treatment response or based on biomarker-guided decisions. This approach aims to minimize cumulative toxicity, reduce adverse effects, and lower treatment burden while maintaining clinical efficacy.","oneSentence":"De-escalation strategy refers to a clinical approach of reducing drug dose, frequency, or intensity of treatment based on patient response or risk assessment.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:32:22.650Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07466238","phase":"NA","title":"HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer","status":"NOT_YET_RECRUITING","sponsor":"Peking University","startDate":"2026-03-15","conditions":"Biliary Tract Cancer (BTC)","enrollment":40},{"nctId":"NCT07438340","phase":"NA","title":"Managing Aggression: Effectiveness of Model-Based Standardized Patient Simulation","status":"NOT_YET_RECRUITING","sponsor":"Yuksek Ihtisas University","startDate":"2026-02","conditions":"Aggression","enrollment":56},{"nctId":"NCT05887557","phase":"NA","title":"Multidisciplinary Low-Barrier and Mobile HIV Care to Improve Retention and Viral Suppression: Stakeholder-Engaged Design and Evaluation","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-05-16","conditions":"HIV","enrollment":400},{"nctId":"NCT03822897","phase":"PHASE2","title":"De-Escalation Radiotherapy in Patients With Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2019-06-28","conditions":"Oropharyngeal Cancer","enrollment":103},{"nctId":"NCT07183319","phase":"PHASE2","title":"Circulating Tumor DNA Response In Urothelial Cancer","status":"RECRUITING","sponsor":"University of Oklahoma","startDate":"2026-01-19","conditions":"Urothelial Carcinoma","enrollment":30},{"nctId":"NCT07153198","phase":"NA","title":"Promoting Socioemotional Development in Early Childhood: Implementation and Evaluation of the VIPP-SD Parenting Intervention in Portugal","status":"RECRUITING","sponsor":"ISPA - Instituto Universitario de Ciencias Psicologicas, Sociais e da Vida","startDate":"2026-01-01","conditions":"Parent-Child Relations","enrollment":120},{"nctId":"NCT05192434","phase":"NA","title":"Trauma Intervention to Optimize PrEP Among Women Who Inject Drugs","status":"ACTIVE_NOT_RECRUITING","sponsor":"Drexel University","startDate":"2022-06-17","conditions":"HIV Infections, Opioid Use, Trauma, Psychological","enrollment":219},{"nctId":"NCT07281586","phase":"PHASE4","title":"Step-down Therapy After Long-term Osteoporosis Treatment","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2026-01-01","conditions":"Osteoporosis","enrollment":44},{"nctId":"NCT07096271","phase":"NA","title":"Get Better Together: Relationship Education For Military Couples","status":"RECRUITING","sponsor":"Henry M. Jackson Foundation for the Advancement of Military Medicine","startDate":"2025-09-22","conditions":"Emotion Regulation, Relationship Conflict, Suicide Risk","enrollment":1000},{"nctId":"NCT04755387","phase":"PHASE4","title":"Ticagrelor De-escalation Strategy in AMI Patients","status":"RECRUITING","sponsor":"Dong-A University","startDate":"2023-03-27","conditions":"Acute Myocardial Infarction","enrollment":2312},{"nctId":"NCT07189325","phase":"PHASE3","title":"A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2025-09","conditions":"Relapsing-Remitting Multiple Sclerosis (RRMS), Anti-CD20 Therapy","enrollment":250},{"nctId":"NCT06390436","phase":"PHASE4","title":"Therapeutic Drug Monitoring-baSed adalimuMab De-escalatiOn in nOn-infecTious cHronic Uveitis","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2025-06","conditions":"Uveitis, Chronic Disease","enrollment":320},{"nctId":"NCT03465644","phase":"PHASE4","title":"TAILored Versus COnventional AntithRombotic StratEgy IntenDed for Complex HIgh-Risk PCI","status":"COMPLETED","sponsor":"Duk-Woo Park, MD","startDate":"2019-02-12","conditions":"Coronary Stenoses","enrollment":2018},{"nctId":"NCT03107793","phase":"PHASE3","title":"Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab","status":"COMPLETED","sponsor":"Janssen-Cilag Ltd.","startDate":"2017-04-19","conditions":"Crohn Disease","enrollment":500},{"nctId":"NCT06933966","phase":"PHASE2","title":"Evaluation of Efficacy and Safety De-escalation Versus Standard Adjuvant Chemotherapy in Patients With Low Risk Localized Gastroesophageal Adenocarcinoma","status":"NOT_YET_RECRUITING","sponsor":"Centre Leon Berard","startDate":"2025-09-01","conditions":"Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma, Non Metastatic Disease","enrollment":120},{"nctId":"NCT04340895","phase":"NA","title":"Study to Assess Effectiveness of Therapy Timely Adjustment Based on Self-monitoring in Patients Suffering From Mild-to-moderate Ulcerative Colitis (OPTIMISE Study)","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2019-10-14","conditions":"Mild-to-moderate Ulcerative Colitis","enrollment":250},{"nctId":"NCT06572514","phase":"PHASE1, PHASE2","title":"De-escalation Radiation Strategy After NAC in Combination With ICI in LAHNSCC","status":"RECRUITING","sponsor":"Ruijin Hospital","startDate":"2023-10-17","conditions":"Locally Advanced Head and Neck Squamous Cell Carcinoma","enrollment":20},{"nctId":"NCT06547671","phase":"NA","title":"Efficacy of a Sensory Comfort Room in Agitation Control","status":"COMPLETED","sponsor":"Bioaraba Health Research Institute","startDate":"2021-05-01","conditions":"Mental Disorders, Severe","enrollment":62},{"nctId":"NCT02842580","phase":"PHASE2","title":"De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal Cancer","status":"TERMINATED","sponsor":"Federation Francophone de Cancerologie Digestive","startDate":"2016-09","conditions":"Colorectal Neoplasms","enrollment":21},{"nctId":"NCT06461481","phase":"","title":"Strategies for Adaptive Follow-up and Evaluation - Guiding Use of Indicators for De-Escalation in Multiple Sclerosis","status":"RECRUITING","sponsor":"Heinrich-Heine University, Duesseldorf","startDate":"2024-06-15","conditions":"Multiple Sclerosis","enrollment":150},{"nctId":"NCT04688528","phase":"NA","title":"Dose De-escalation and Sentinel LN Mapping Driven Radiotherapy of Contralateral Neck in Ipsilateral Node Positive HNSCC","status":"RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2021-06-10","conditions":"Squamous Cell Carcinoma of Head and Neck","enrollment":147},{"nctId":"NCT06414187","phase":"NA","title":"Clinical Effects of Intra-aortic Balloon Support in Early Acute Coronary Syndrome and Non-Acute Coronary Syndrome Related Cardiogenic Shock","status":"NOT_YET_RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2024-06-01","conditions":"Cardiogenic Shock","enrollment":400},{"nctId":"NCT03538912","phase":"NA","title":"Early Discontinuation of Empirical Antifungal Therapy and Biomarkers","status":"RECRUITING","sponsor":"University Hospital, Lille","startDate":"2018-06-06","conditions":"Invasive Candidiasis","enrollment":194},{"nctId":"NCT06257147","phase":"NA","title":"Antimicrobial Stewardship for Enterobacterales Bacteremia Management","status":"NOT_YET_RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2024-05-01","conditions":"Infections","enrollment":420},{"nctId":"NCT05336955","phase":"NA","title":"Evaluation of Telehealth Services on Mental Health Outcomes for People With Intellectual and Developmental Disabilities","status":"RECRUITING","sponsor":"University of New Hampshire","startDate":"2023-05-01","conditions":"Mental Health Conditions, Developmental Disability","enrollment":500},{"nctId":"NCT05903976","phase":"PHASE3","title":"De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent ACS","status":"UNKNOWN","sponsor":"Azienda Ospedaliera Universitaria Policlinico \"G. Martino\"","startDate":"2023-06-12","conditions":"Dual Antiplatelet Therapy, Acute Coronary Syndrome, Coronary Artery Disease","enrollment":200},{"nctId":"NCT05914402","phase":"NA","title":"Axillary Surgery De-escalation After Neoadjuvant Therapy Using Dedicate Breast PET","status":"UNKNOWN","sponsor":"Fudan University","startDate":"2023-06-18","conditions":"Breast Cancer","enrollment":100},{"nctId":"NCT04718025","phase":"PHASE3","title":"Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome","status":"UNKNOWN","sponsor":"Collegium Medicum w Bydgoszczy","startDate":"2022-02-07","conditions":"STEMI, NSTEMI, Unstable Angina","enrollment":4500},{"nctId":"NCT05813821","phase":"NA","title":"7-VINCut Antibiotic Stewardship Intervention to Decrease Duration of Antibiotic Treatment and Carbapenem Use in Surgery","status":"COMPLETED","sponsor":"Hospital de Granollers","startDate":"2019-01-01","conditions":"Medication Adherence, Antibiotic Resistance, Microbial, Medication Errors and Other Product Use Errors and Issues","enrollment":32499},{"nctId":"NCT02104986","phase":"PHASE2","title":"A Multicenter Study to Evaluate a Risk-adapted Strategy for Treatment of Extra Cranial Non Seminomateous Malignant Germ Cell Tumour in Children and Adolescent","status":"COMPLETED","sponsor":"Centre Leon Berard","startDate":"2014-05-12","conditions":"Extra Cranial Non Seminomateous Malignant Germ Cell Tumour","enrollment":117},{"nctId":"NCT01491815","phase":"PHASE4","title":"Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose Reduction","status":"UNKNOWN","sponsor":"Karolinska Institutet","startDate":"2012-12-14","conditions":"Rheumatoid Arthritis","enrollment":812},{"nctId":"NCT03617133","phase":"PHASE2","title":"Image Guided IMRT, Radiochemotherapy and MRI-based IGABT in Locally Advanced Cervical Cancer","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2016-04","conditions":"Uterine Cervical Neoplasms","enrollment":1000},{"nctId":"NCT05210595","phase":"PHASE4","title":"Optimal Dosage of Ticagrelor in Korean Patients With AMI","status":"UNKNOWN","sponsor":"Dong-A University","startDate":"2022-01-01","conditions":"Acute Myocardial Infarction, Ticagrelor","enrollment":120},{"nctId":"NCT04848766","phase":"","title":"IPD Meta-analysis of De-escalation Treatment Strategy After PCI in ACS","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2021-06-07","conditions":"Acute Coronary Syndrome, Coronary Artery Disease","enrollment":9000},{"nctId":"NCT04781829","phase":"NA","title":"Use of a Rapid Diagnostic Test for Antibiotic De-escalation in Severe Community Acquired Pneumonia","status":"WITHDRAWN","sponsor":"Northwestern University","startDate":"2020-01-15","conditions":"Community-acquired Pneumonia","enrollment":""},{"nctId":"NCT01363258","phase":"NA","title":"Reducing Care-Resistant Behaviors During Oral Hygiene in Persons With Dementia","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2011-04","conditions":"Care-resistant Behavior, Dementia","enrollment":100},{"nctId":"NCT01626612","phase":"PHASE3","title":"De-escalation of Empirical Antimicrobial Therapy Study in Severe Sepsis","status":"COMPLETED","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2012-02","conditions":"Severe Sepsis","enrollment":120},{"nctId":"NCT01066013","phase":"NA","title":"Antimicrobial De-escalation Strategy in Medical Patients","status":"UNKNOWN","sponsor":"Fraser Health","startDate":"2010-02","conditions":"Infections","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":165,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Ticagrelor 60 mg, aspirin early discontinuation"],"phase":"marketed","status":"active","brandName":"De-escalation strategy","genericName":"De-escalation strategy","companyName":"Dong-A University","companyId":"dong-a-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}